Coronavirus - we're here to help
From how to access your account online, scam awareness, your wellbeing and our community we're here to help.

Skip to main content
  • Register
  • Help
  • Contact us
  • Log out of your HL account

Polar Capital Healthcare Opportunities Class I - Income (GBP)

Sell:4,555.00p Buy:4,555.00p Change: 60.00p (1.34%)
Prices as at 6 July 2020
Sell:4,555.00p
Buy:4,555.00p
Change: 60.00p (1.34%)
You can buy or sell holdings in this fund through a Stocks and Shares ISA, Lifetime ISA, SIPP or Fund and Share Account
Prices as at 6 July 2020
Sell:4,555.00p
Buy:4,555.00p
Change: 60.00p (1.34%)
Prices as at 6 July 2020
You can buy or sell holdings in this fund through a Stocks and Shares ISA, Lifetime ISA, SIPP or Fund and Share Account
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Our view on this Fund

This fund does not feature on the Wealth Shortlist of funds our analysts believe have the potential to outperform their peers over the long term. This is not a recommendation to sell; however, if you are thinking of adding to your investments, we believe the Wealth Shortlist is a good place to start. View funds on the Wealth Shortlist »

Our view on the sector

Our view on the sector for this fund is not available.

Performance Analysis

Performance analysis for this fund is not available.

Investment Philosophy

Investment philosophy for this fund is not available.

Process and Portfolio Construction

Process and portfolio construction for this fund are not available.

question mark Manager Track Record Based on HL Quantitative Research

This information is currently unavailable.

Fund Track Record

06/07/15 to 06/07/16 06/07/16 to 06/07/17 06/07/17 to 06/07/18 06/07/18 to 06/07/19 06/07/19 to 06/07/20
Annual return 2.13% 13.79% 13.63% 11.97% 11.76%

Please remember past performance is not a guide to future returns. Where no data is shown, figures are not available. This information is provided to help you choose your own investments, remember they can fall as well as rise in value so you may not get back the original amount invested.

Fund Management Group Comment

Polar Capital is a research-driven, specialist investment management company. It has been steadily growing its assets and range of products since forming in 2001; and now manages a large number of funds on behalf of a wide range of investors. The group listed on the Alternative Investment Market (AIM) in February 2007, although approximately 36% of the company remains in the hands of directors, founders and employees. The company is predominantly based in London but maintains offices in Edinburgh, Tokyo, Connecticut, Jersey and Geneva.

Information about the fund

Fund manager biography

manager photo
Manager Name: Gareth Powell
Manager start date: 3 December 2007
Manager located in: London

Gareth joined Polar Capital in 2007 to set up the healthcare team. He has over 18 years' investment experience in the healthcare sector, with 14 years as a Portfolio Manager. Prior to Polar Capital, Gareth worked at Framlington, where he began his career in investment management in 1999. Soon afterwards, he began managing the Framlington Health Fund and in 2002 he helped launch the Framlington Biotech Fund, which he managed from 2004 until his departure. Gareth studied biochemistry at Oxford, during which time he worked at Yamanouchi, a leading Japanese pharmaceutical company (later to become Astellas), as well as various academic laboratories including the Sir William Dunn School of Pathology, the Wolfson Institute for Biomedical Research and Oxford Business School. He is a CFA charterholder.

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Benchmark data provided subject to this disclaimer.
You can buy or sell holdings in this fund through a Stocks and Shares ISA, Lifetime ISA, SIPP or Fund and Share Account